Lumark Oral Solution TM

lumarkoral

 

 

 

 

 

 

 

 

 

GENERIC FORM STRENGTH PRESENTATION INDICATION
Levetiracetam Oral Solution 100mg/ml 60ml bottle

Indicated as Mono therapy in the treatment of Partial onset of seizures with or without secandary generalisation in patients from 16 yrs of age with newly diagnosed epilepsy.

Levetiracetam is indicated as adjunctive therapy:

In the treatment of partial seizure with or without secandary generalisation in adults and children from 4 years of age with epilepsy.

In the treatment of myoclonic seizures in adults and adolescents from 12 yrs of age with Juvenile myoclonic epilepsy.

In thj treatment of primary generalised tonic-clonic seizures  in adults and adolescents from 12 Yrs of age with Idiopathic generalised epilepsy .